InvestLog
BBIO BridgeBio Pharma, Inc. logo

BBIO BridgeBio Pharma, Inc.

Healthcare
$67.73-2.01%ClosedMarket Cap: $13.27B

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

5

Dispositions

35

Buy/Sell Ratio

0.14

Net Shares

-249,382

Shares Acquired

81,215

Shares Disposed

330,597

Total Bought ($)

$0.00

Total Sold ($)

$27.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Tue May 19Trimarchi Thomasofficer: President and CFOSell10,456$64.82362,389
Tue May 19Trimarchi Thomasofficer: President and CFOSell3,195$65.95359,194
Tue May 19Trimarchi Thomasofficer: President and CFOSell22,781$66.13372,845
Tue May 19Kumar Neildirector, officer: Chief Executive OfficerSell33,544$0.00267,995
Tue May 19Kumar Neildirector, officer: Chief Executive OfficerSell19,599$0.00287,594
Tue May 19Kumar Neildirector, officer: Chief Executive OfficerSell11,553$0.00299,147
Tue May 19Kumar Neildirector, officer: Chief Executive OfficerSell6,519$0.00305,666
Tue May 19Kumar Neildirector, officer: Chief Executive OfficerSell36,236$66.13269,430
Mon May 11Kumar Neildirector, officer: Chief Executive OfficerSell13,974$66.654,364,473
Mon May 11Kumar Neildirector, officer: Chief Executive OfficerSell13,973$66.65561,713
Mon May 11Kumar Neildirector, officer: Chief Executive OfficerSell11,217$67.494,387,230
Mon May 11Kumar Neildirector, officer: Chief Executive OfficerSell8,334$68.384,378,896
Mon May 11Kumar Neildirector, officer: Chief Executive OfficerSell8,333$68.38576,136
Mon May 11Kumar Neildirector, officer: Chief Executive OfficerSell5,076$67.354,359,397
Mon May 11Kumar Neildirector, officer: Chief Executive OfficerSell950$68.354,358,447